About Shanghai MicroPort Endovascular MedTech
Shanghai MicroPort Endovascular MedTech is a company based in Shanghai (China) founded in 2012.. The company has 826 employees as of December 31, 2024. Shanghai MicroPort Endovascular MedTech operates in a competitive market with competitors including Endologix, Endoron Medical, Trivascular, Altura Medical and Aptus Endosystems, among others.
- Headquarter Shanghai, China
- Employees 826 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Shanghai Microport Endovascular Medtech Co., Ltd Class A
-
Annual Revenue
$164.4 M (USD)1.76as on Dec 31, 2024
-
Net Profit
$68.79 M (USD)1.96as on Dec 31, 2024
-
EBITDA
$79.14 M (USD)-0.1as on Dec 31, 2024
-
Latest Funding Round
-
Investors
5Y Capital
& 1 more
-
Employee Count
826
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Shanghai MicroPort Endovascular MedTech
Shanghai MicroPort Endovascular MedTech is a publicly listed company on the SSE with ticker symbol 688016 in China, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of Shanghai MicroPort Endovascular MedTech
- Total Funding Total Funding
- Total Rounds 1
- Last Round Last Round
- First Round First Round
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2018 | Amount | Series A - Shanghai MicroPort Endovascular MedTech | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Shanghai MicroPort Endovascular MedTech
Shanghai MicroPort Endovascular MedTech has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include 5Y Capital and CICC Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A venture capital firm focused on technology and innovation investments.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Shanghai MicroPort Endovascular MedTech
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Shanghai MicroPort Endovascular MedTech
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Shanghai Microport Endovascular Medtech Comparisons
Competitors of Shanghai MicroPort Endovascular MedTech
Shanghai MicroPort Endovascular MedTech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Endologix, Endoron Medical, Trivascular, Altura Medical and Aptus Endosystems, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Minimally invasive treatments for aortic disorders are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
Endovascular fixation devices for cardiovascular stent grafts are manufactured.
|
|
| domain | founded_year | HQ Location |
Designs and manufactures for endovascular aortic repair equipment
|
|
| domain | founded_year | HQ Location |
Endovascular devices for aortic aneurysms are developed.
|
|
| domain | founded_year | HQ Location |
Endograft anchoring systems for aortic aneurysms are developed.
|
|
| domain | founded_year | HQ Location |
Miniature implants are developed to monitor intra-aneurysm pressure and hemodynamics.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Shanghai Microport Endovascular Medtech
Frequently Asked Questions about Shanghai MicroPort Endovascular MedTech
When was Shanghai MicroPort Endovascular MedTech founded?
Shanghai MicroPort Endovascular MedTech was founded in 2012 and raised its 1st funding round 6 years after it was founded.
Where is Shanghai MicroPort Endovascular MedTech located?
Shanghai MicroPort Endovascular MedTech is headquartered in Shanghai, China.
How many employees does Shanghai MicroPort Endovascular MedTech have?
As of Dec 31, 2024, the latest employee count at Shanghai MicroPort Endovascular MedTech is 826.
What is the annual revenue of Shanghai MicroPort Endovascular MedTech?
Annual revenue of Shanghai MicroPort Endovascular MedTech is $164.4M as on Dec 31, 2024.
What does Shanghai MicroPort Endovascular MedTech do?
Shanghai MicroPort Endovascular MedTech was founded in 2012 in Shanghai, China. Medical devices targeted at aortic and peripheral diseases are developed within the endovascular medtech sector. Products including stent graft systems for aortic dissection and abdominal aortic aneurysms, bifurcated stent grafts, and balloon inflation catheters have been created for surgical applications. Operations emphasize device innovation for vascular treatments in the region.
Who are the top competitors of Shanghai MicroPort Endovascular MedTech?
Shanghai MicroPort Endovascular MedTech's top competitors include Endologix, Trivascular and Jotec.
Is Shanghai MicroPort Endovascular MedTech publicly traded?
Yes, Shanghai MicroPort Endovascular MedTech is publicly traded on SSE under the ticker symbol 688016.
Who are Shanghai MicroPort Endovascular MedTech's investors?
Shanghai MicroPort Endovascular MedTech has 2 investors. Key investors include 5Y Capital, and CICC Capital.
What is Shanghai MicroPort Endovascular MedTech's ticker symbol?
The ticker symbol of Shanghai MicroPort Endovascular MedTech is 688016 on SSE.